- CA$47.39m
- CA$35.86m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.43 | ||
| Price to Tang. Book | 3.43 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -57.85% | ||
| Return on Equity | -52.25% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Apr | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Myriad Uranium Corp. is a Canada-based uranium exploration company. The Company holds a 100% interest in the Copper Mountain Uranium Project in Wyoming, United States. Copper Mountain hosts several historic uranium deposits and past-producing mines, including the Arrowhead Mine (approximately 500,000 lbs U₃O₈ produced). The Company holds exploration license 10577 in the Province of Nova Scotia. The license comprises 80 mineral claims covering approximately 1,280 hectares, known as the Millen Mountain Property. The Millen Mountain property has Meguma-style gold deposits including tightly folded meta-sediments. The Company also holds 10% free interest carried in the Red Basin Uranium Project. Its 100%-owned Breccia Pipe Project in Arizona comprises at least 23 breccia pipes that are prospective for uranium and rare earth elements (REEs). The Company's subsidiary is Rush Rare Metals Corp.
Directors
- Last Annual
- April 30th, 2026
- Last Interim
- July 31st, 2026
- Incorporated
- October 5th, 2018
- Public Since
- November 5th, 2019
- Sector
- Metals & Mining
- Industry
- Basic Materials
- Exchange
Canadian Securities Exchange- Shares in Issue
- 143,616,542
- Address
- #600-1090 W. Georgia St., VANCOUVER, V6E 3V7
- Web
- https://myriaduranium.com
- Phone
- +1 6048996401
- Auditors
- Davidson & Company LLP
Similar to M
26 Metals
Canadian Securities Exchange
37 Capital
Canadian Securities Exchange
55 North Gold
Canadian Securities Exchange
Abitibi Greenstone Gold
Canadian Securities Exchange
Abitibi Metals
Canadian Securities Exchange
FAQ
As of Today at 22:12 UTC, shares in Myriad Uranium are trading at CA$0.33. This share price information is delayed by 15 minutes.
Shares in Myriad Uranium last closed at CA$0.33 and the price had moved by -29.03% over the past 365 days. In terms of relative price strength the Myriad Uranium share price has underperformed the Toronto Stock Exchange 300 Composite Index by -39.81% over the past year.
The overall consensus recommendation for Myriad Uranium is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMyriad Uranium does not currently pay a dividend.
Myriad Uranium does not currently pay a dividend.
Myriad Uranium does not currently pay a dividend.
To buy shares in Myriad Uranium you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.33, shares in Myriad Uranium had a market capitalisation of CA$47.39m.
Here are the trading details for Myriad Uranium:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: M
Based on an overall assessment of its quality, value and momentum Myriad Uranium is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Myriad Uranium is CA$1.20. That is 263.64% above the last closing price of CA$0.33.
Analysts covering Myriad Uranium currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Myriad Uranium. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -36.36%.
As of the last closing price of CA$0.33, shares in Myriad Uranium were trading -29.58% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Myriad Uranium PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Myriad Uranium's directors